Overview
- 38 inspections across 38 sites are on record.
- 25 Form 483 observations are attributed to this investigator.
- Most recent recorded activity is 2026-06-12.
At a glance
Inspections
38
Sites
38
Observations
25
Career since
Jun 2023
Recent inspections
Most recent inspections in the published record.
| Site | Date | Category | Form 483 |
|---|---|---|---|
| Alison C. Bested, MD | 12 Jun 2026 | Human Drugs | On file |
| Adonis Maiquez, M.D. | 20 May 2026 | Human Drugs | |
| Yves Dauvilliers, M.D., Ph.D. | 28 Apr 2026 | Human Drugs | On file |
| Riccardo Papa, M.D., Ph.D. | 17 Apr 2026 | Human Drugs | |
| Summit Therapeutics, Inc. | 10 Apr 2026 | Human Drugs |
Sites inspected
Alison C. Bested, MDDavie, United States1 insp.
Adonis Maiquez, M.D.Miami, United States1 insp.
Yves Dauvilliers, M.D., Ph.D.Montpellier, France1 insp.
Riccardo Papa, M.D., Ph.D.Genoa, Italy1 insp.
Summit Therapeutics, Inc.Palo Alto, United States1 insp.
Co-investigators
Investigators who share inspections with this person.
Angelica M Chica3 shared
Emily A Baldwin2 shared
Ana P Barido2 shared
Ricardo Vela2 shared
Jose A Torres1 shared
Ashley J Burns1 shared
Hugh M Mcclure1 shared
Richard A Lyght1 shared
Full investigator report
Get the verbatim findings behind Chantae D Mitchell's 25 observations
Source 483 PDFs, verbatim observations, and how each site responded, so your team knows what they cite before they arrive.
- New inspections and Form 483s, mapped to the CFR citation
- Warning letter outcomes, and the citation patterns they repeat
- Their co-investigators, so no surprises about who shows up on site